AeroVironment: The Drones Are Winning, The P&L Isn't (Yet)

# AeroVironment: The Drones Are Winning, The P&L Isn't (Yet)

Here's a fun exercise: try to find two data points on AeroVironment that agree with each other. Current price is $190, or it's $142. Revenue grew 133%, or it grew 140.89%. The stock just hit a 52-week low, or it's riding a three-day, 35% face-ripper higher. Welcome to AVAV coverage in 2026 — a stock where the bull case and the bear case are apparently reporting from different planets, and somehow both are right.

Let's cut through the noise, because underneath the conflicting headlines there's a real story, and it's a good one — just not an uncomplicated one.

The catalysts are legit. AeroVironment landed a $500 million firm-fixed-price Army contract for its Titan RF counter-drone system, running through 2029. That's not a press-release contract — that's multi-year revenue visibility in a category (counter-UAS) that every NATO defense ministry is suddenly desperate to fund. Layer on a book-to-bill ratio of 1.4x, a funded backlog that jumped 65% to $1.2 billion, and fresh wins in Italy (JUMP 20 designation) and Germany (Puma fleet expansion under the LARUS program), and you've got a company that is unambiguously winning the land-grab in autonomous defense systems. Switchblade, Puma, and Raven now account for 77% of sales — this is no longer a niche drone shop, it's becoming defense-tech infrastructure.

But here's the part the "moderate buy" crowd keeps skipping past. This is a company still bleeding cash. Free cash flow sits at negative $251 million. TTM EPS is negative $5.40. Net margins are running at -13.41%. And the stock, even after its recent surge, is trading at a forward P/E north of 31 — for a business that isn't yet profitable on a GAAP basis. You don't pay a growth-stock multiple and get growth-stock cash generation. Right now, AVAV investors are paying up front for a profitability story that hasn't shown up on the income statement.

That's not disqualifying — defense primes with lumpy government contracts routinely run this way, and the acquisitions (BlueHalo, Empirical Systems) are adding real non-cash drag to the GAAP numbers while presumably building capability. Adjusted EBITDA margin of 21.8% suggests the underlying engine isn't broken. But "adjusted" is doing a lot of work in that sentence, and investors chasing the momentum need to be honest about what they're actually buying: a story stock with a defense-budget tailwind, not a cash machine.

The technical picture backs up the "don't get greedy" instinct. Resistance sits stubbornly in the $142–$150 zone, RSI readings have swung from an overbought-adjacent 60 down to a tepid 41 depending on which week you check, and the 52-week range — $135.20 to a jaw-dropping $417.86 — tells you this stock has already proven it can be extremely emotional in both directions. Support at $135.20 is the line in the sand; below it, the "accumulate on dips" thesis needs a rewrite.

Competitively, the knives are out too. Shield AI and Skydio aren't sitting still, and they're better funded on the software/autonomy side than AeroVironment's legacy hardware pedigree might suggest. AVAV's moat is its incumbency with the Pentagon and NATO allies — real, but not unbreachable, especially if a venture-backed challenger out-executes on AI-native autonomy.

The bottom line: July 8's Investor Day and the fiscal 2027 guidance (revenue target $2.125–$2.225 billion) are the actual tell here, not the headline price target of $258 that assumes everything goes right. Backlog conversion is the whole ballgame. If AeroVironment can turn that $1.2 billion backlog into cash flow instead of just GAAP noise, this becomes a legitimately profitable defense-tech compounder. If it can't, you own an expensive story stock with great press releases and a stubborn habit of losing money.

Accumulate on weakness toward the mid-$130s if you believe in the defense-budget supercycle. Just don't confuse a hot contract pipeline with a hot balance sheet — they are not currently the same thing.